Streetbeat News

Products Services

WW

WW International is exploring alternatives to branded weight-loss drugs, as reported by Bloomberg.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 1:24 pm

CIFR

IREN

RIOT

WULF

July saw a stark contrast in the Bitcoin mining sector, with traditional miners like Cipher Mining and Riot Platforms thriving, while AI-exposed miners such as Iris Energy and TeraWulf faced significant setbacks. The broader Bitcoin market experienced volatility, with prices fluctuating and mining profitability declining.

Portfolio Pulse from Surbhi Jain

August 01, 2024 | 1:23 pm

BIIB

Biogen executive states that concerns raised by the European Medicines Agency (EMA) regarding their Alzheimer's drug can be addressed with the available data.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 1:23 pm

NRSN

NeuroSense Therapeutics announced positive 12-month biomarker data from its Phase 2b clinical trial for PrimeC, showing significant improvements in ALS-related biological markers, safety, and efficacy. The trial demonstrated reduced functional and respiratory deterioration, regulation of iron levels, and improved survival rates.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 1:22 pm

BITW

BTCUSD

The cryptocurrency landscape is evolving rapidly, with significant political support emerging from both Republican and Democratic circles in the U.S. This shift is exemplified by proposals such as a national Bitcoin stockpile and potential Treasury acquisitions. Bitwise CIO Matt Hougan highlights the need for investors to recalibrate their expectations, noting both significant downside risks and expanded upside potential.

Portfolio Pulse from Murtuza Merchant

August 01, 2024 | 1:21 pm

NVDA

SMCI

Supermicro has launched a new plug-and-play SuperCluster optimized for NVIDIA Omniverse, featuring up to 256 advanced NVIDIA PCIe GPUs. This solution aims to enhance performance for 3D and AI workloads at enterprise scale.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 1:20 pm

NXE

NexGen Energy Ltd. has updated the economic estimates for its Rook I Project, revising the capital cost to $1.58 billion USD. The project is expected to generate an average annual after-tax net cash flow of C$1.93 billion in the first five years, with a consistent mine life and production capability of up to 30 million pounds of U3O8 annually. The updated costs reflect inflationary changes and advancements in engineering and procurement.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 1:18 pm

ADV

Advantage Solutions Inc. (NASDAQ:ADV) has expanded its strategic alliance with Swiftly, a retail technology provider. This collaboration enhances Advantage's omnichannel capabilities, allowing retailers to manage their digital relationships with shoppers more effectively. The integration of Swiftly's technology enables brands to execute comprehensive marketing campaigns and gain valuable analytics from first-party data.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 1:17 pm

BIMI

EW

MRK

The article highlights three oversold health care stocks with RSI values near or below 30, indicating potential buying opportunities. The stocks mentioned are BIMI Holdings Inc (NASDAQ:BIMI), Edwards Lifesciences Corp (NYSE:EW), and Merck & Co Inc (NYSE:MRK).

Portfolio Pulse from Avi Kapoor

August 01, 2024 | 1:16 pm

SNGX

Soligenix, Inc. (NASDAQ:SNGX) plans to initiate patient enrollment in the confirmatory FLASH 2 study with HyBryte™ by the end of 2024. The company is also exploring the potential of HyBryte™ in treating other dermatological conditions such as psoriasis, with a Phase 2 study ongoing.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 1:13 pm